Akros Pharma
NJ - Princeton
PharmaceuticalFocus: Develops products for JT Pharmaceuticals
Akros Pharma is a life sciences company focused on Develops products for JT Pharmaceuticals.
Neurology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Illumination with blue light
Leg Ulcers VenousClinical Trials (1)
NCT04018924Blu Light for Ulcers Reduction
N/AJTZ-951, 14C-JTZ-951
Anemia of Chronic Kidney DiseaseClinical Trials (1)
NCT02805244Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis
Phase 1Phase 1
Clinical Trials (1)
NCT01978587Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
Phase 1JTT-252 or Placebo
Diabetes MellitusClinical Trials (1)
NCT02120976Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252
Phase 1JTT-662
Diabetes Mellitus, Type 2Clinical Trials (1)
NCT04465877Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes
Phase 1JTK-853, ketoconazole
HealthyClinical Trials (1)
NCT01473069Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects
Phase 1Phase 1
Clinical Trials (1)
NCT07247266Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)
Phase 1JTE-451
Plaque PsoriasisClinical Trials (1)
NCT03018509Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects
Phase 1JTK-853 or Placebo
HealthyClinical Trials (1)
NCT01475981Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects
Phase 1Phase 1
Clinical Trials (1)
NCT01971164Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
Phase 1JTT-251 or Placebo
Diabetes MellitusClinical Trials (1)
NCT02106585Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects
Phase 1Phase 1
Clinical Trials (1)
NCT01473056Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects
Phase 1Phase 1
Clinical Trials (1)
NCT02581124Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
Phase 1Phase 2
Clinical Trials (1)
NCT03789643Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension
Phase 2JTE-451 Tablets
Plaque PsoriasisClinical Trials (1)
NCT03832738Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
Phase 2JTT-302
DyslipidemiaClinical Trials (1)
NCT00748852Safety Study of JTT-302 in Subjects With Low HDL-C Levels
Phase 2JTT-705 600 mg and atorvastatin 20 mg
DyslipidemiaClinical Trials (1)
NCT00689442Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Phase 2JTT-130
Type II Diabetes MellitusClinical Trials (1)
NCT00929539Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients
Phase 2JTE-051
Plaque PsoriasisClinical Trials (1)
NCT03358290Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
Phase 2JTT-851
Type 2 Diabetes MellitusClinical Trials (1)
NCT01699737Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Phase 2JTT-654
Type II Diabetes MellitusClinical Trials (1)
NCT00997152Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients
Phase 2JTT-861 Capsules
Chronic Heart FailureClinical Trials (1)
NCT06017609Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
Phase 2JTT-705 600 mg and pravastatin 40 mg
Type II HyperlipidemiaClinical Trials (1)
NCT00688896Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
Phase 2JTT-302
DyslipidemiaClinical Trials (1)
NCT00749788Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels
Phase 2JTE-051
Rheumatoid ArthritisClinical Trials (1)
NCT02919475Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis
Phase 2JTT-705 600 mg and simvastatin 40 mg
DyslipidemiaClinical Trials (1)
NCT00688558Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Phase 2Reactive Focal Drug Administration
MalariaClinical Trials (1)
NCT02654912Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 27 clinical trials